FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

(MedPage Today) -- The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
Dubbed IsoPSA, the in vitro diagnostic kit is indicated for men ages 50...